Financial report is a formal document, commonly issued at the turn of an accounting period and containing a structurally presented description of a company’s financial activities and results. A financial report usually covers a financial position, equity changes and provides company’s balance sheet, income and cash flow statements.
Financial reports represent a reliable as well as relevant source of data used to support businesses in the decision making process. Financial reports can be prepared both for internal (for the company’s employees and owners) and external use (for present and potential investors, lenders, shareholders, etc.).
This MarketPublishers’ catalogue provides a great plenitude of the financial reports of various companies. The researches offer detailed examination of a company’s strategic and operational performance as well as scrutinize the investment climate; review the business divisions; present SWOT analyses; list company’s products and services. The reports contain brief overviews of companies’ historic background and include clear pictures of the companies’ actual market positions.
Publications found:
9,254
Sort by:
The 2012 Top Ten World's Leading Diagnostic Imaging Companies
US$ 10,000.00
... establish a comprehensive, factual, annually updated and cost-effective information base on performance, capabilities, goals and strategies of the world’s leading diagnostic imaging companies. To help current suppliers realistically assess their financial, technological and marketing capabilities vis-à-vis ...
March 2012
850 pages
The 2012 Leading Diagnostic Imaging Companies Strategic Directions
US$ 2,000.00
For each company, the report provides insightful strategic assessments, including: Business, new product development, and marketing strategies. Anticipated acquisitions, joint ventures, and divestitures. The companies analyzed in the report: Aloka, Analogic, Esaote, GE, Hitachi, Hologic, Philips, Shimadzu ...
March 2012
41 pages
The 2012 Leading Diagnostic Imaging Companies Marketing Tactics
US$ 2,000.00
For each company, the analysis presents: The U.S. and international sales force size in major geographic regions. Selling options, including rental plans, leasing and others. Promotional tactics, e.g., pricing, discounts, advertising, trade shows, seminars, product literature, newsletters, etc. System ...
March 2012
50 pages
The 2012 Leading Diagnostic Imaging Companies Comparative Analysis
US$ 680.00
This report ranks the world’s major diagnostic imaging companies according to the following criteria: Sales and market shares in the U.S., Europe, Japan and other geographic regions. Sales by modality. Operating profit and margins. R&D expenditures. The ...
March 2012
5 pages
The 2012 Leading Diagnostic Imaging Companies Financial Analyses
US$ 1,960.00
Each company’s analysis provides: Sales estimates by division, geographic region, and modality. Five-year sales and operating profit performance. The companies analyzed in the report: Aloka, Analogic, Esaote, GE, Hitachi, Hologic, Philips, Shimadzu, Siemens, and Toshiba. Contains 92 pages and 78 tables
March 2012
92 pages
The 2012 Leading Diagnostic Imaging Companies Organizations and Management
US$ 1,480.00
... and strategies. Recent acquisitions, divestitures, and significant organizational changes. Current organizational structure. Management philosophy and attitudes toward the diagnostic imaging market. Background of key executives. The companies analyzed in the report: Aloka, Analogic, Esaote, GE, Hitachi, ...
March 2012
92 pages
The 2012 Leading Diagnostic Imaging Companies Technological Know-How
US$ 1,480.00
For each company, the report analyzes: Internally developed and acquired diagnostic imaging and related technologies, including X-ray, ultrasound, MRI, CT, nuclear medicine, PET, PACS, and others. The companies analyzed in the report: Aloka, Analogic, Esaote, GE, Hitachi, Hologic, Philips, Shimadzu, Siemens ...
March 2012
60 pages
The 2012 Leading Diagnostic Imaging Companies Product Portfolio Analyses
US$ 1,480.00
For each company, the analyses present: Placements and installed base of major systems in the U.S. and abroad, by modality. Review of major product lines. Specifications, features, advantages, weaknesses, introduction dates and prices of current systems. The companies analyzed in the report: Aloka, ...
March 2012
230 pages
The 2012 Leading Diagnostics Imaging Companies Facilities and Employees
US$ 1,480.00
For each company, the analyses present: Location and size of administrative, manufacturing, and R&D facilities in the U.S. and abroad. New plants under construction. U.S. and international work force size and distribution. The companies analyzed in the report: Aloka, Analogic, Esaote, GE, Hitachi, ...
March 2012
32 pages
The 2011 Top Ten World's Leading Life Science Intermediates Companies
US$ 10,000.00
... include: To establish a comprehensive, factual and cost-effective information base on performance, capabilities, goals and strategies of the world’s leading life science intermediates companies. To help current suppliers realistically assess their financial, technological and marketing capabilities vis-a- ...
October 2010
600 pages
The 2011Global Life Science Intermediates Market Dynamics and Trends
US$ 1,480.00
... PDF: US$ 3,900.00 A concise market analysis, including: Major U.S. and international trends with potentially significant impact on the life science intermediates industry during the next five years, including industry consolidation, market globalization, environmental regulations, etc. Analysis of major ...
October 2010
29 pages
The 2011 Leading Life Science Intermediates Companies Marketing Tactics
US$ 1,480.00
Global PDF: US$ 3,900.00 For each company, the analysis presents: Major promotional strategies. Distribution approaches. Product service and support. The companies analyzed in the report: BASF, Bayer/Lanxess, Cambrex, Clariant, DowPharma, DSM, Evonik, Lonza, Novasep, and Rhodia. Contains 20 pages
October 2010
20 pages
The 2011 Leading Life Science Intermediates Companies Comparative Analysis
US$ 680.00
Global PDF: US$ 1,900.00 This report ranks the world’s major life science intermediates companies according to the following criteria: Estimated sales in Europe, North America, Asia, and other geographic regions. Operating profit. R&D expenditures. The companies analyzed in the report: BASF, Bayer/ ...
October 2010
5 pages
